-
1
-
-
0036184873
-
Infections diagnosed in the first year after pediatric stem cell transplantation
-
Benjamin, D. K., Jr., W. C. Miller, S. Bayliff, L. Martel, K. A. Alexander, and P. L. Martin. 2002. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr. Infect. Dis. J. 21:227-234.
-
(2002)
Pediatr. Infect. Dis. J.
, vol.21
, pp. 227-234
-
-
Benjamin Jr., D.K.1
Miller, W.C.2
Bayliff, S.3
Martel, L.4
Alexander, K.A.5
Martin, P.L.6
-
2
-
-
0345201630
-
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients
-
Chavez, M., S. Bernal, A. Valverde, M. J. Gutierrez, G. Quindos, and E. M. Mazuelos. 1999. In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients. J. Antimicrob. Chemother. 44:697-700.
-
(1999)
J. Antimicrob. Chemother.
, vol.44
, pp. 697-700
-
-
Chavez, M.1
Bernal, S.2
Valverde, A.3
Gutierrez, M.J.4
Quindos, G.5
Mazuelos, E.M.6
-
3
-
-
0033825590
-
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B
-
Cuenca-Estrella, M., E. Mellado, T. M. Diaz-Guerra, A. Monzon, and J. L. Rodriguez-Tudela. 2000. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. J. Antimicrob. Chemother. 46:475-477.
-
(2000)
J. Antimicrob. Chemother.
, vol.46
, pp. 475-477
-
-
Cuenca-Estrella, M.1
Mellado, E.2
Diaz-Guerra, T.M.3
Monzon, A.4
Rodriguez-Tudela, J.L.5
-
4
-
-
16844366147
-
Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine
-
Dowell, J. A., M. Stogniew, D. Krause, T. Henkel, and I. E. Weston. 2005. Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine. J. Clin, Pharmacol. 45:227-233.
-
(2005)
J. Clin, Pharmacol.
, vol.45
, pp. 227-233
-
-
Dowell, J.A.1
Stogniew, M.2
Krause, D.3
Henkel, T.4
Weston, I.E.5
-
5
-
-
2442695447
-
Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal
-
Dowell, J. A., W. Knebel, T. Ludden, M. Stogniew, D. Krause, and T. Henkel. 2004. Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal. J. Clin. Pharmacol. 44:590-598.
-
(2004)
J. Clin. Pharmacol.
, vol.44
, pp. 590-598
-
-
Dowell, J.A.1
Knebel, W.2
Ludden, T.3
Stogniew, M.4
Krause, D.5
Henkel, T.6
-
6
-
-
0031689491
-
Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
-
Espinel-Ingroff, A. 1998. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956.
-
(1998)
J. Clin. Microbiol.
, vol.36
, pp. 2950-2956
-
-
Espinel-Ingroff, A.1
-
7
-
-
0034812542
-
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): Reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
-
Groll, A. H., D. Mickiene, R. Petraitiene, V. Petraitis, C. A. Lyman, J. S. Bacher, S. C. Piscitelli, and T. J. Walsh. 2001. Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling. Antimicrob. Agents Chemother. 45:2845-2855.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 2845-2855
-
-
Groll, A.H.1
Mickiene, D.2
Petraitiene, R.3
Petraitis, V.4
Lyman, C.A.5
Bacher, J.S.6
Piscitelli, S.C.7
Walsh, T.J.8
-
8
-
-
0031833836
-
Evaluation of endpoints for antifungal susceptibility determinations with LY303366
-
Klepser, M. E., E. J. Ernst, M. E. Ernst, S. A. Messer, and M. A. Pfaller. 1998. Evaluation of endpoints for antifungal susceptibility determinations with LY303366. Antimicrob. Agents Chemother. 42:1387-1391.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 1387-1391
-
-
Klepser, M.E.1
Ernst, E.J.2
Ernst, M.E.3
Messer, S.A.4
Pfaller, M.A.5
-
9
-
-
0035239765
-
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species
-
Moore, C. B., K. L. Oakley, and D. W. Denning. 2001. In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species. Clin. Microbiol. Infect. 7:11-16.
-
(2001)
Clin. Microbiol. Infect.
, vol.7
, pp. 11-16
-
-
Moore, C.B.1
Oakley, K.L.2
Denning, D.W.3
-
10
-
-
33646783722
-
-
[Online.] National Institutes of Health, Bethesda, Md.
-
National Institutes of Health. 1999. Common toxicity criteria for adverse events, v2.0. [Online.] National Institutes of Health, Bethesda, Md. http://ctep.cancer.gov/reporting/.
-
(1999)
Common Toxicity Criteria for Adverse Events, V2.0
-
-
-
11
-
-
10744224705
-
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States
-
Ostrosky-Zeichner, L., J. H. Rex, P. G. Pappas, R. J. Hamill, R. A. Larsen, H. W. Horowitz, W. G. Powderly, N. Hyslop, C. A. Kauffman, J. Cleary, J. E. Mangino, and J. Lee. 2003. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob. Agents Chemother. 47:3149-3154.
-
(2003)
Antimicrob. Agents Chemother.
, vol.47
, pp. 3149-3154
-
-
Ostrosky-Zeichner, L.1
Rex, J.H.2
Pappas, P.G.3
Hamill, R.J.4
Larsen, R.A.5
Horowitz, H.W.6
Powderly, W.G.7
Hyslop, N.8
Kauffman, C.A.9
Cleary, J.10
Mangino, J.E.11
Lee, J.12
-
12
-
-
0032824392
-
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits
-
Petraitiene, R., V. Petraitis, A. H. Groll, M. Candelario, T. Sein, A. Bell, C. A. Lyman, C. L. McMillian, J. Bacher, and T. J. Walsh. 1999. Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits. Antimicrob. Agents Chemother. 43:2148-2155.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 2148-2155
-
-
Petraitiene, R.1
Petraitis, V.2
Groll, A.H.3
Candelario, M.4
Sein, T.5
Bell, A.6
Lyman, C.A.7
McMillian, C.L.8
Bacher, J.9
Walsh, T.J.10
-
13
-
-
0031783659
-
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits
-
Petraitis, V., R. Petraitiene, A. H. Groll, A. Bell, D. P. Callender, T. Sein, R. L. Schaufele, C. L. McMillian, J. Bacher, and T. J. Walsh. 1998. Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob. Agents Chemother. 42:2898-2905.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 2898-2905
-
-
Petraitis, V.1
Petraitiene, R.2
Groll, A.H.3
Bell, A.4
Callender, D.P.5
Sein, T.6
Schaufele, R.L.7
McMillian, C.L.8
Bacher, J.9
Walsh, T.J.10
-
14
-
-
0035139521
-
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
-
Petraitis, V., R. Petraitiene, A. H. Groll, T. Sein, R. L. Schaufele, C. A. Lyman, A. Francesconi, J. Bacher, S. C. Piscitelli, and T. J. Walsh. 2001. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. Antimicrob. Agents Chemother. 45:471-479.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 471-479
-
-
Petraitis, V.1
Petraitiene, R.2
Groll, A.H.3
Sein, T.4
Schaufele, R.L.5
Lyman, C.A.6
Francesconi, A.7
Bacher, J.8
Piscitelli, S.C.9
Walsh, T.J.10
-
15
-
-
0031943562
-
In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi
-
Pfaller, M. A., F. Marco, S. A. Messer, and R. N. Jones. 1998. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn. Microbiol. Infect. Dis. 30:251-255.
-
(1998)
Diagn. Microbiol. Infect. Dis.
, vol.30
, pp. 251-255
-
-
Pfaller, M.A.1
Marco, F.2
Messer, S.A.3
Jones, R.N.4
-
17
-
-
27644585388
-
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
-
Walsh, T. J., P. C. Adamson, N. L. Seibel, P. M. Flynn, M. N. Neely, C. Schwartz, A. Shad, S. L. Kaplan, M. M. Roden, J. A. Stone, A. Miller, S. K. Bradshaw, S. X. Li, C. A. Sable, and N. A. Kartsonis. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob. Agents Chemother. 49:4536-4545.
-
Antimicrob. Agents Chemother.
, vol.49
, pp. 4536-4545
-
-
Walsh, T.J.1
Adamson, P.C.2
Seibel, N.L.3
Flynn, P.M.4
Neely, M.N.5
Schwartz, C.6
Shad, A.7
Kaplan, S.L.8
Roden, M.M.9
Stone, J.A.10
Miller, A.11
Bradshaw, S.K.12
Li, S.X.13
Sable, C.A.14
Kartsonis, N.A.15
-
18
-
-
3142782023
-
Risk factors for disseminated candidiasis in children with candidemia
-
Zaoutis, T. E., H. M. Greves, E. Lautenbach, W. B. Bilker, and S. E. Coffin. 2004. Risk factors for disseminated candidiasis in children with candidemia. Pediatr. Infect. Dis. J. 23:635-641.
-
(2004)
Pediatr. Infect. Dis. J.
, vol.23
, pp. 635-641
-
-
Zaoutis, T.E.1
Greves, H.M.2
Lautenbach, E.3
Bilker, W.B.4
Coffin, S.E.5
-
19
-
-
0030896919
-
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis. and Aspergillus species
-
Zhanel, G. G., J. A. Karlowsky, G. A. Harding, T. V. Balko, S. A. Zelenitsky, M. Friesen, A. Kabani, M. Turik, and D. J. Hoban. 1997. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis. and Aspergillus species. Antimicrob. Agents Chemother. 41:863-865.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 863-865
-
-
Zhanel, G.G.1
Karlowsky, J.A.2
Harding, G.A.3
Balko, T.V.4
Zelenitsky, S.A.5
Friesen, M.6
Kabani, A.7
Turik, M.8
Hoban, D.J.9
|